Transplantation of pancreatic beta-cells prevents development of hypothalamic obesity in rats.
Level 5 - mechanism / opinion, no new human data
Non-human animal experimental study.
PubMed 100013 · doi:10.1152/ajpendo.1978.235.3.E266
What was done
Rats were rendered diabetic with streptozotocin to destroy native pancreatic beta-cells and then cured via fetal pancreatic tissue transplants placed under the renal capsule. Ventromedial hypothalamic (VMH) lesions were subsequently created in these transplanted rats and in sham-transplanted control rats with intact native pancreases. Animals were followed for 4 weeks to monitor body weight, food intake, insulin levels, and islet morphology.
What was found
VMH-lesioned rats with denervated pancreatic transplants gained no more weight than sham-operated controls and showed no significant increase in insulin. In contrast, VMH-lesioned rats with intact native pancreases demonstrated the expected post-lesion rise in insulin and islet hypertrophy. Food intake rose by 71% in VMH-lesioned rats with intact beta-cells versus only 23% in VMH-lesioned rats with pancreatic transplants.
Why it matters
This study provides mechanistic evidence that neural drive to the pancreas, rather than a purely circulating or metabolic signal, mediates the hyperinsulinemia and subsequent hyperphagia and obesity triggered by ventromedial hypothalamic injury.
Limits
The study was conducted entirely in a rodent model over a 4-week observation period. The abstract does not report sample sizes, baseline values, absolute weight numbers, or statistical dispersion metrics.
Cited by
- supports In animal studies, lesioning the hypothalamus causes hypothalamic obesity by placing the neural connection between the brain and the pancreas for insulin release into hyperdrive.